early April for topline data analysis to be finalized and, soon after, be released to the press! Looking to generate revenue in a broad setting, and making deals with individual companies to provide lantibiotics while still undergoing R&D to pinpoint what proteins in the strain are most effective to treating patients. No purification or sterilization is involved since they are naturally-occuring antibiotics, therefore their profit margins will be insanely high in the manufacturing process. Im even more freaking excited for the press release!!